Showing results (141-150 of 861) with videos related to
Sort By:
Pageof 87
Comptes Rendus De L'Academie Des Sciences. Serie III, Sciences De La Vie|January 1, 1984
[A new specificity for anti-DNA antibodies]L Jacob, F Tron, D Louvard, et al.Proceedings of the National Academy of Sciences of the United States of America|June 1, 1984
A monoclonal anti-DNA antibody also binds to cell-surface protein(s)L Jacob, F Tron, J F Bach, et al.Clinical Immunology and Immunopathology|September 1, 1989
Male BXSB mice develop a thymic hormonal dysfunction with presence of intraepithelial crystalline inclusionsM Dardenne, W Savino, B Nabarra, et al.European Journal of Immunology|October 1, 1989
Syngeneic T cell transfer of diabetes into NOD newborn mice: in situ studies of the autoimmune steps leading to insulin-producing cell destructionP Bedossa, A Bendelac, J F Bach, et al.Clinical and Experimental Immunology|April 1, 1987
Protective effect of myasthenic immunoglobulins against the lethal toxicity of alpha bungarotoxinB Vernet-der Garabedian, J F Bach, E MorelEuropean Journal of Immunology|August 1, 1986
Fine specificity of antibodies produced in rhesus monkeys following in vivo treatment with anti-T cell murine monoclonal antibodiesF Villemain, M Jonker, J F Bach, et al.Journal of Immunological Methods|January 1, 1977
Detection of circulating immune complexes in human sera by simplified assays with polyethylene glycolM Digeon, M Laver, J Riza, et al.Journal of Autoimmunity|June 1, 1989
The role of class II major histocompatibility complex antigens in autoimmune diabetes: animal modelsJ Timsit, W Savino, C Boitard, et al.Comptes Rendus De L'Academie Des Sciences. Serie III, Sciences De La Vie|January 1, 1984
[Heterogeneity of antibodies blocking the binding of bungarotoxin to the acetylcholine receptor in myasthenia]B Vernet-der-Garabédian, E Morel, J F BachComptes Rendus De L'Academie Des Sciences. Serie III, Sciences De La Vie|January 1, 1992
[Remission of established disease in diabetic NOD mice induced by anti-CD3 monoclonal antibody]L Chatenoud, E Thervet, J Primo, et al.Pageof 87